| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
0.9551 -0.035 (-0.04%) |
03-22 10:00 |
|
Open: |
0.95 |
Pre close: |
0.99 |
Target:
|
1.24 
|
|
High: |
0.9601 |
Low: |
0.95 |
Resistance:
|
1.06
1.24
|
|
Volume: |
35,548 |
Market Cap: |
112M |
Support:
|
0.97
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.99
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.99  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.03 |
Stochastic Oscillator |
%K(14,3):
|
63.33 |
|
MA(250): |
1.19 |
%D(3): |
61.73 |
|
Average Volume(K) |
3-Month: |
24232
|
52-Week |
High:
|
1.52 |
|
10-Days: |
31527 |
Low: |
0.66 |
|
RSI |
RSI(14):
|
48.04 |
Change(%): |
-28.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.180 |
Return on Equity (ttm) |
-107.3 |
Shares Out. (M) |
116.86 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-81.1 |
Shares Float (M) |
101.20 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.10 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
7.70 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
7.570 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.50 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.13 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.14 |
P/S |
0.00 |
|
Operating Margin |
-65046.30 |
Levered Free Cash Flow
(M) |
-15.23 |
P/CF |
-4.11 |
|
|
|
|
|
|
